SPEX:LSE:LSE-Invesco S&P 500 Equal Weight Index ETF Acc GBP (GBX)

ETF | Others |

Last Closing

USD 4890.25

Change

+8.75 (+0.18)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+13.00 (+5.79%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.86 (+2.38%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.07 (+0.38%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.35%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.60 (+2.52%)

USD 266.08B
0QZO:LSE 0QZO

+2.00 (+1.79%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 244.75B
0QZ3:LSE Qualcomm Inc.

+1.75 (+1.02%)

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing SPEX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.33% 72% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.33% 72% C 67% D+
Trailing 12 Months  
Capital Gain 18.98% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.98% 71% C- 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.42% 53% F 59% D-
Dividend Return 7.42% 52% F 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.60% 73% C 85% B
Risk Adjusted Return 86.29% 82% B 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike